News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
106
Sources here
16
Companies here
1
Search results Stored financial headlines

Active search

106 matching headlines

Ticker or company: ADMAMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

PR Newswire Regulatory and legal Main company 🇺🇸 United States

ADMA DEADLINE: The Gross Law Firm Reminds ADMA Biologics, Inc. Investors of Upcoming Securities Class Action Deadline

The Gross Law Firm is reminding investors of ADMA Biologics, Inc. (NASDAQ: ADMA) about an upcoming securities class action deadline of August 10, 2026. The lawsuit alleges that ADMA Biologics issued materially false and/or misleading statements, including engaging in an undisclosed related party transaction, …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors

The Portnoy Law Firm has announced a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA Biologics and its executives made false and misleading statements by …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GuruFocus Regulatory and legal Main company 🇺🇸 United States

ADMA Stock Drop: ADMA Biologics Channel Stuffing Allegations Lead to 29% Stock Drop and Securities Fraud Class Action for Investors

A securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. and its executives following a 29% stock drop. The lawsuit alleges that ADMA engaged in a channel stuffing scheme to inflate revenue growth, purportedly driven by claims from Culper Research. Investors …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
DirectorsTalk Interviews Earnings Main company 🇺🇸 United States

ADMA Biologics Inc (ADMA) Stock Analysis: A Look At Its 100.95% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) is highlighted as a compelling investment in the biotechnology sector, specializing in plasma-derived biologics for immune deficiencies. Analysts are bullish, projecting a potential upside of 100.95% from its current trading price, with an average target price of $17.00. The …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The National Law Review Regulatory and legal Main company 🇺🇸 United States

Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologic

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against ADMA Biologics, Inc. following a short report from Culper Research. The report alleges that ADMA's reported growth is artificial, driven by a "channel stuffing scheme and an undisclosed related party distributor," leading to a …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

ADMA BIOLOGICS CLASS ACTION DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

Bragar Eagel & Squire, P.C. is reminding ADMA Biologics, Inc. stockholders that the deadline to apply to be lead plaintiff in a class action lawsuit is August 10, 2026. The lawsuit alleges that ADMA made false or misleading statements regarding its business, including an …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

ADMA Biologics Inc expected to post earnings of 17 cents a share - Earnings Preview

ADMA Biologics Inc is expected to report earnings of 17 cents per share. This information comes from a Refinitiv earnings preview. The full article is available to TradingView subscribers.

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TMX Newsfile Regulatory and legal Main company 🇺🇸 United States

ADMA INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the August 10, 2026 Lead Plaintiff Deadline ADMA Biologics, Inc. Securities Class Action

Holzer & Holzer, LLC has filed a shareholder class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA), alleging the company made false and misleading statements, including an undisclosed related party transaction, channel stuffing, and inadequate internal controls. Investors who purchased ADMA shares between August …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL,

Rosen Law Firm is reminding investors of ADMA Biologics, Inc. (NASDAQ: ADMA) who incurred losses exceeding $100K during the Class Period (August 9, 2024, to March 25, 2026) to secure legal counsel. The deadline to move for lead plaintiff in the securities class action …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

ADMA Class Action Notice: ADMA Biologics Hit with Securities Fraud Lawsuit over Channel Stuffing Misrepresentations – Investors Urged to Contact BFA Law by August 10 Deadline

ADMA Biologics is facing a securities fraud class action lawsuit due to allegations of a "channel stuffing" scheme that misrepresented its 2025 revenue growth. The lawsuit follows a report by Culper Research, which claimed ADMA artificially inflated its reported 20% growth by inducing a …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Market update Main company 🇺🇸 United States

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BitGo Holdings, Inc. (BTGO), ADMA Biologics, Inc. (ADMA), and Via Transportation, Inc. (VIA) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC reminds investors of upcoming lead plaintiff deadlines in shareholder class action lawsuits against BitGo Holdings, Inc. (BTGO), ADMA Biologics, Inc. (ADMA), and Via Transportation, Inc. (VIA). Investors who suffered losses in these companies are encouraged to contact the firm to …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
PR Newswire Regulatory and legal Main company 🇺🇸 United States

ADMA Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

The Rosen Law Firm reminds investors of ADMA Biologics, Inc. who incurred losses exceeding $100,000 during the August 9, 2024, to March 25, 2026, Class Period, about the August 10, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that ADMA …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Caledonian Record Regulatory and legal Main company 🇺🇸 United States

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with ...

The Rosen Law Firm is reminding investors of ADMA Biologics, Inc. (NASDAQ: ADMA) who purchased securities between August 9, 2024, and March 25, 2026, about the August 10, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that ADMA Biologics …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

In the latest close session, Adma Biologics (ADMA) was down 2.42% at $8.46. This change lagged the S&P 500's daily gain of 0.7%. Meanwhile, the Dow experienced a rise of 0.53%, and the technology-dominated Nasdaq saw an increase of 1%. Shares of the infectious …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential

Lowey Dannenberg P.C. is investigating ADMA Biologics (NASDAQ: ADMA) for potential federal securities laws violations based on a report by Culper Research. The report alleges that ADMA Biologics engaged in "channel stuffing" in 2025 by inducing a distributor to overstock ASCENIV with rebates and …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Carroll County Mirror-Democrat Regulatory and legal Main company 🇺🇸 United States

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA Biologics, Inc. Lawsuit - ADMA

The Gross Law Firm is reminding shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) about an August 10, 2026, deadline to seek lead plaintiff appointment in a class action lawsuit. The lawsuit alleges that ADMA Biologics made materially false and misleading statements, engaged in an …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

$ADMA Securities: Suffer Losses on Your ADMA Biologics Investment? BFA Law Reminds Investors of the Securities Fraud Lawsuit to Recover Losses

Bleichmar Fonti & Auld LLP has filed a class action lawsuit against ADMA Biologics, Inc. (NASDAQ:ADMA) for securities fraud. The lawsuit alleges that ADMA engaged in a "channel stuffing" scheme to inflate its 2025 revenue growth, leading to a significant stock drop after Culper …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
globenewswire.com Regulatory and legal Main company 🇺🇸 United States

ADMA 10-DAY DEADLINE ALERT: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit– HBSS

SAN FRANCISCO, July 30, 2026 (GLOBE NEWSWIRE) -- Hagens Berman alerts investors in ADMA Biologics, Inc. (NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company’s financial condition, revenue recognition, inventory distribution, and …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TMX Newsfile Regulatory and legal Main company 🇺🇸 United States

ADMA INVESTOR DEADLINE: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before August 10, 2026 Deadline

Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against ADMA Biologics, Inc. for alleged violations of the Securities Exchange Act of 1934. Purchasers of ADMA publicly traded securities between August 9, 2024, and March 25, 2026, have until August 10, 2026, …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

ClaimsFiler is alerting investors of ADMA Biologics, Inc. (NasdaqGM: ADMA) that they have until August 10, 2026, to apply for lead plaintiff in a securities class action lawsuit. The lawsuit alleges that ADMA and its executives made false and misleading statements and omissions regarding …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
ACCESS Newswire Regulatory and legal Main company 🇺🇸 United States

Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Before August 10, 2026 to Join Class Action

Levi & Korsinsky, LLP has announced a securities class action lawsuit against ADMA Biologics, Inc. for investors who purchased securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA Biologics made false statements and concealed an undisclosed related party transaction, …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
PR Newswire Regulatory and legal Main company 🇺🇸 United States

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against ADMA Biologics, Inc. for investors who suffered losses. The lawsuit alleges that ADMA engaged in an undisclosed related party transaction, used channel stuffing to inflate revenue, and lacked adequate …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
PR Newswire Regulatory and legal Main company 🇺🇸 United States

Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 10, 2026 - ADMA

Levi & Korsinsky, LLP reminds investors of ADMA Biologics, Inc. (NASDAQ: ADMA) about a pending class action lawsuit with an August 10, 2026, lead plaintiff deadline. The lawsuit alleges that ADMA engaged in a "channel stuffing" scheme to inflate ASCENIV revenues from August 9, …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
globenewswire.com Regulatory and legal Main company 🇺🇸 United States

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA) of the August 10, 2026 deadline involving a securities fraud class action lawsuit commenced against the …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Analyst action Main company 🇺🇸 United States

Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The Manila Times Earnings Main company 🇺🇸 United States

ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026

ADMA Biologics, Inc. announced it will release its second quarter 2026 financial results on August 5, 2026, after the U.S. financial markets close. The company's management will host a conference call and audio webcast at 4:30 p.m. ET on the same day to discuss …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

ADMA Biologics Sets Aug. 5 Webcast for Second-Quarter Results

ADMA Biologics (Nasdaq: ADMA) will report its second-quarter 2026 financial results on August 5, 2026, after the U.S. markets close, followed by a live conference call and audio webcast at 4:30 p.m. ET. Participants are required to register in advance for the call to …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Morningstar Regulatory and legal Main company 🇺🇸 United States

ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

The Gross Law Firm has issued a shareholder alert regarding a securities class action lawsuit against ADMA Biologics, Inc. Investors who purchased shares between August 9, 2024, and March 25, 2026, are encouraged to contact the firm, as the company is accused of making …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Regulatory and legal Main company 🇺🇸 United States

ADMA Class Reminder: ADMA Biologics Investors are Reminded of the Upcoming August 10 Deadline in the Filed Securities Fraud Class Action to Recover Losses

Bleichmar Fonti & Auld LLP has filed a securities fraud class action lawsuit against ADMA Biologics Inc. and its executives, following a significant stock drop. The lawsuit alleges that ADMA engaged in a channel stuffing scheme to inflate its 2025 growth figures for its …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇺🇸 United States

Adma Biologics (ADMA) Rises Higher Than Market: Key Facts

In the latest trading session, Adma Biologics (ADMA) closed at $8.48, marking a +2.54% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.02%. Elsewhere, the Dow saw an upswing of 0.51%, while the tech-heavy Nasdaq …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

ADMA Biologics Inc (ADMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for ADMA Biologics Inc (ADMA), highlighting its regional revenue distribution. As of the latest update, 98.80% of its revenue, totaling $504.07M, comes from the United States, with International sales contributing 1.20% ($6.11M). The company has not yet disclosed …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

Did You Lose Money Investing in ADMA Biologics, Inc.

Robbins LLP has announced a class action lawsuit against ADMA Biologics, Inc. (ADMA) on behalf of investors who purchased securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA misled investors by engaging in an undisclosed related party transaction, using …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Caledonian Record Regulatory and legal Main company 🇺🇸 United States

ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff Deadline in ADMA BIOLOGICS, INC. ...

Levi & Korsinsky, LLP reminds purchasers of ADMA Biologics, Inc. (NASDAQ: ADMA) securities of a pending securities class action with a lead plaintiff deadline of August 10, 2026. The lawsuit alleges that ADMA made materially false or misleading statements regarding its revenue recognition practices …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
ACCESS Newswire Regulatory and legal Main company 🇺🇸 United States

August 10, 2026 Deadline Approaching: Join Class Action Against ADMA Biologics, Inc. (ADMA) - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a securities class action lawsuit against ADMA Biologics, Inc. (NASDAQ:ADMA) on behalf of investors who suffered losses due to alleged securities fraud. The lawsuit claims ADMA Biologics made false statements, engaged in an undisclosed related party transaction, used …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

ADMA Biologics Inc|Price:8.270

ADMA Biologics Inc. is a commercial biopharmaceutical company specializing in plasma-derived biologics for immunodeficient patients and those at risk of infections. The company manufactures and markets three FDA-approved products: ASCENIV, BIVIGAM, and NABI-HB, and operates an FDA-approved plasma collection subsidiary, ADMA BioCenters. Key executives …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026
globenewswire.com Regulatory and legal Main company 🇺🇸 United States

$ADMA Fraud Notification: ADMA Biologics Sued for Fraud Over Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and certain of the Company’s senior executives for securities fraud after its significant …

ADMA main company
Sharemaestro market context Price below Trend Line 52 weeks -46.8% ADMA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context